この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2009/5/51 分で読めます
Revision of the Requirements for Publication of License Revocation; Companion Document to Direct Final Rule
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is proposing to amend the biologics regulations to clarify the regulatory procedures for notifying the public about the revocation of a biologics license to be consistent with current practices. This proposed rule is a companion document to the direct final rule published elsewhere in this issue of the Federal Register.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →